JP2001506915A - 陰イオン交換材料およびその方法 - Google Patents
陰イオン交換材料およびその方法Info
- Publication number
- JP2001506915A JP2001506915A JP52336498A JP52336498A JP2001506915A JP 2001506915 A JP2001506915 A JP 2001506915A JP 52336498 A JP52336498 A JP 52336498A JP 52336498 A JP52336498 A JP 52336498A JP 2001506915 A JP2001506915 A JP 2001506915A
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkylene
- groups
- monomer
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 34
- 238000005349 anion exchange Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title claims description 54
- 239000000178 monomer Substances 0.000 claims abstract description 88
- 229920000642 polymer Polymers 0.000 claims abstract description 72
- 239000000758 substrate Substances 0.000 claims abstract description 42
- 150000001768 cations Chemical class 0.000 claims abstract description 25
- 238000005342 ion exchange Methods 0.000 claims abstract description 18
- 125000002091 cationic group Chemical group 0.000 claims description 41
- -1 siloxane substituent Chemical group 0.000 claims description 28
- 125000002947 alkylene group Chemical group 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- 229910052757 nitrogen Inorganic materials 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 125000001153 fluoro group Chemical group F* 0.000 claims description 17
- 125000000129 anionic group Chemical group 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000000962 organic group Chemical group 0.000 claims description 14
- 229910052698 phosphorus Inorganic materials 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 150000002500 ions Chemical class 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- 229920001897 terpolymer Polymers 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- 150000001449 anionic compounds Chemical class 0.000 claims description 8
- 150000001450 anions Chemical group 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 6
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 125000000524 functional group Chemical group 0.000 claims description 5
- 125000003010 ionic group Chemical group 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium group Chemical group [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000005275 alkylenearyl group Chemical group 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 claims description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 239000004254 Ammonium phosphate Substances 0.000 claims 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims 1
- 235000019289 ammonium phosphates Nutrition 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 229920001971 elastomer Polymers 0.000 claims 1
- 125000005496 phosphonium group Chemical group 0.000 claims 1
- 229920000098 polyolefin Polymers 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 229920000669 heparin Polymers 0.000 abstract description 71
- 229960002897 heparin Drugs 0.000 abstract description 71
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract description 70
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 19
- 239000002953 phosphate buffered saline Substances 0.000 description 17
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000460 chlorine Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 238000001179 sorption measurement Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 239000003999 initiator Substances 0.000 description 9
- 102000008946 Fibrinogen Human genes 0.000 description 8
- 108010049003 Fibrinogen Proteins 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 229940012952 fibrinogen Drugs 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 7
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 7
- 229940011051 isopropyl acetate Drugs 0.000 description 7
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000023555 blood coagulation Effects 0.000 description 5
- 210000001772 blood platelet Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229910001873 dinitrogen Inorganic materials 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 125000001165 hydrophobic group Chemical group 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000011056 performance test Methods 0.000 description 4
- 239000011877 solvent mixture Substances 0.000 description 4
- PZJJKWKADRNWSW-UHFFFAOYSA-N trimethoxysilicon Chemical group CO[Si](OC)OC PZJJKWKADRNWSW-UHFFFAOYSA-N 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005276 aerator Methods 0.000 description 3
- 239000013060 biological fluid Substances 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GYXOHPLRXDQGBP-UHFFFAOYSA-M 2-hydroxyethyl(trimethyl)azanium;2-methylprop-2-enoate Chemical compound CC(=C)C([O-])=O.C[N+](C)(C)CCO GYXOHPLRXDQGBP-UHFFFAOYSA-M 0.000 description 2
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 108010074860 Factor Xa Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 102000007625 Hirudins Human genes 0.000 description 2
- 108010007267 Hirudins Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229940117913 acrylamide Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 2
- 229940006607 hirudin Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003335 secondary amines Chemical group 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- QLOKJRIVRGCVIM-UHFFFAOYSA-N 1-[(4-methylsulfanylphenyl)methyl]piperazine Chemical compound C1=CC(SC)=CC=C1CN1CCNCC1 QLOKJRIVRGCVIM-UHFFFAOYSA-N 0.000 description 1
- LUYAMNYBNTVQJG-UHFFFAOYSA-N 1-chloro-2-(2-chloroethylsulfonyl)ethane Chemical group ClCCS(=O)(=O)CCCl LUYAMNYBNTVQJG-UHFFFAOYSA-N 0.000 description 1
- XFGANBYCJWQYBI-UHFFFAOYSA-N 11-bromoundecan-1-ol Chemical compound OCCCCCCCCCCCBr XFGANBYCJWQYBI-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001676573 Minium Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- IYXMNTLBLQNMLM-UHFFFAOYSA-N benzene-1,4-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=C(N)C=C1 IYXMNTLBLQNMLM-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000004803 chlorobenzyl group Chemical group 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- QPMJENKZJUFOON-PLNGDYQASA-N ethyl (z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/Cl)C(F)(F)F QPMJENKZJUFOON-PLNGDYQASA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000004442 gravimetric analysis Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000007981 phosphate-citrate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- JOHZPMXAZQZXHR-UHFFFAOYSA-N pipemidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCNCC1 JOHZPMXAZQZXHR-UHFFFAOYSA-N 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000012492 regenerant Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000012257 stirred material Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.溶解したまたは懸濁した陰イオン性化合物を含む水溶液を、ペンダント な陽イオン性の基およびおよび陰イオン性の対イオンを有する陰イオン交換材料 と接触させ、これによって陰イオン性化合物を対イオンとイオン交換するイオン 交換法であって、イオン交換材料もまたペンダントな両性イオンの基を有するこ とを特徴とする方法。 2.ペンダントな両性イオンの基において、その陽イオン性の部分が永久的 な陽イオン、好ましくは第4級アンモニウム基であることを特徴とする請求項1 記載の方法。 3.ペンダントな両性イオンの基において、その陰イオン性の部分がフォス フェートまたはフォスフォネート基、好ましくはフォスフェートジエステル基で あることを特徴とする請求項1又は2記載の方法。 4.ペンダントな陽イオンの基が基N+R5 3、P+R5 3またはS+R5 2であり 、ここで基R5は同一または相異なり、それぞれC1 〜4アルキルまたはアリール (好ましくはフェニル)であるか、或いは2個の基R5はそれが結合しているヘ テロ原子と一緒になって炭素原子を5〜7個含む飽和または不飽和の複素環を形 成し、好ましくはQ1はN+R5 3であり、ここでR5はC1 〜4−アルキル、好まし くはメチルであることを特徴とする上記の請求項のいずれかに記載の方法。 5.陰イオン交換材料はペンダントな両性イオンの基およびペンダントな陽 イオンの基を有する重合体で被覆された基質を含むことを特徴とする上記の請求 項のいずれかに記載の方法。 6.該重合体が (a)式I YBX I 式中Bは結合であるか、または直鎖または分岐鎖のアルキレン、アルキレ ン−オキサ−アルキレン、またはアルキレン−オリゴオキサ−アルキレン基であ り、そのいずれも場合により1個またはそれ以上のフッ素置換基を含んでおり、 Xは両性イオン部分を有する有機基であり、そして Yはエチレン型不飽和の重合可能な基である、 の両性イオン性単量体、および (b)式II Y1B1Q1 II 式中B1は結合であるか、または直鎖または分岐鎖のアルキレン、アルキ レン−オキサ−アルキレン、またはアルキレン−オリゴオキサ−アルキレン基で あり、そのいずれも場合により1個またはそれ以上のフッ素置換基を含んでおり 、 Y1はエチレン型不飽和の重合可能な基であり、そして Qは陽イオン部分を有する有機基である、 の陽イオン性単量体、 を含む単量体から形成されることを特徴とする請求項5記載の方法。 7.単量体がさらに式III Y2B2Q2 III 式中B2は結合であるか、または直鎖または分岐鎖のアルキレン、アルキ レン−オキサ−アルキレン、またはアルキレン−オリゴオキサ−アルキレン基で あり、そのいずれも場合により1個またはそれ以上のフッ素置換基を含んでおり 、 Y2はエチレン型不飽和の重合可能な基であり、そして Q2は炭素数が少なくとも6のアルキル基、フッ素置換されたアルキル基 、および少なくとも1個のシロキサン置換基を有するアルキル基から選ばれる疎 水性の基を有する有機基である、 の疎水性の単量体を含んでいることを特徴とする請求項6記載の方法。 8.B2およびQ2が共にC6 〜24−アルキル基、好ましくは場合により炭素 −炭素間不飽和結合を含む直鎖のアルキル基、好ましくはC8 〜16−アルキルを 表すことを特徴とする請求項7記載の三元重合体。 9.単量体がさらに式IV Y3B3Q3 IV 式中B3は結合であるか、または直鎖または分岐鎖のアルキレン、アルキ レン−オキサ−アルキレン、またはアルキレン−オリゴオキサ−アルキレン基で あり、そのいずれも場合により1個またはそれ以上のフッ素置換基を含んでおり 、 Y3はエチレン型不飽和の重合可能な基であり、そして Q3は外部から刺激を加えた場合基質の表面上にあるか或いは重合体上で ペンダントになっている一緒に反応する基と反応し得る反応性の基を有する有機 基である、 の架橋可能な共重合単量体を含んでいることを特徴とする請求項6〜8のいずれ かに記載の方法。 10.Y、Y1、Y2およびY3はそれぞれ独立に 式中Rは水素またはC1〜C4アルキル基であり、 Aは−O−または−NR1−であって、ここでR1は水素またはC1〜C4ア ルキル基であるか、R1は−B−X、B1Q1、B2Q2、またはB3Q3であり、B 、B1、B2、B3、Q1、Q2およびQ3、並びにXはそれぞれ式I、II、III およびIVに関連して上記に定義した意味を有し、 Kは基−(CH2)pOC(O)−、−(CH2)pC(O)O−、−(CH2)p OC(O)O−、−(CH2)pNR2−、−(CH2)pNR2C(O)−、−(C H2)pC(O)NR2−、−(CH2)pNR2C(O)O−、−(CH2)pOC( O)NR2−、−(CH2)pNR2C(O)NR2−(ここで基R2は同一または相 異なる)、−(CH2)pO−、−(CH2)pSO3−、または場合によりBと一 緒になった原子価結合であり、pは1〜12、R2は水素またはC1〜C4アルキ ル基である、 から選ばれ、好ましくはY、Y1、Y2およびY3はそれぞれ同じ基を表すことを 特徴とする請求項5〜9のいずれかに記載の方法。 11.B、B1、B2およびB3はそれぞれ直鎖または分岐鎖のC1 〜24アルキレ ン基を表すことを特徴とする請求項6〜10のいずれかに記載の方法。 12.Xは燐酸アンモニウムエステル基を表し、両性イオン単量体は好ましく は式VI 式中R、AおよびBは請求項2記載の意味を有し、 基R3は同一または相異なり、それぞれ水素、C1 〜24アルキル、アリール 、アルカリール、アラルキルであるか、または2個または3個の基R3はそれが 結合する窒素原子と一緒になって飽和または不飽和の複素環を形成し、eは1〜 6、好ましくは2〜4である、 を有することを特徴とする請求項5〜10のいずれかに記載の方法。 13.溶液がその中に陰イオン的に帯電したムコポリサッカリドを懸濁または 溶解していることを特徴とする上記請求項のいずれかに記載の方法。 14.基N+R5 3、P+R5 3またはS+R5 2である式Q1のペンダントな陽イオン 性の基、 ここで基R5は同一または相異なり、それぞれC1 〜4アルキルまたはアリ ール(好ましくはフェニル)であるか、或いは2個の基R5はそれが結合してい るヘテロ原子と一緒になって炭素原子を5〜7個含む飽和または不飽和の複素環 を形成しており、そして 陽イオン性の部分が第4級アンモニウムもしくはフォスフォニウム基、または第 3級スルフォニウム基であるペンダントな両性イオンの基Xを有する基質を含む ことを特徴とするイオン交換材料。 15.両性イオンXの陰イオンの部分がフォスフェート基またはフォスフォネ ート基、好ましくはフォスフェートジエステルであることを特徴とする請求項1 4記載の材料。 16.Xが式 式中部位X1およびX2は同一または相異なり、−O−、S−、−NH−ま たは原子価結合、好ましく、は−O−であり、W+はアンモニウム、フォスフォ ニウムおよびスルフォニウムの陽イオン性の基、および陰イオン性部分と陽イオ ン性部分とを連結する好ましくはC1 〜12アルキレン基から成る基である、 の基であることを特徴とする請求項15記載の材料。 17.Wが陽イオンの基としてアンモニウム基、好ましくは第4級アンモニウ ム基を含んでいることを特徴とする請求項16記載の材料。 18.W+は式−W1−N+R23 3、−W1−P+R23a 3、−W1−S+R23a 3、また は−W1−Het+の中の一つの基であり、 ここでW1は炭素数が1以上、好ましくは2〜6のアルキレンであって、 場合により1個またはそれ以上のエチレン型の不飽和二重または三重結合、二置 換アリール、アルキレンアリール、アリールアルキレン、またはアルキレンアリ ールアルキレン、二置換シクロアルキル、アルキレンシクロアルキル、シクロア ルキルアルキレンまたはアルキレンシクロアルキルアルキレンを含み、またW1 基は場合により1個またはそれ以上の弗素置換基および/または1個またはそれ 以上の官能基を含み、そして 基R23は同一または相異なり、それぞれ水素または炭素数1〜4のアルキ ル、好ましくはメチル、またはアリール、例えばフェニルであるか、あるいは二 つの基R23がそれと結合した窒素原子と一緒になって5〜7個の炭素原子を含む 複素環を形成するか、或いはまた3個の基R23がそれと結合した窒素原子と一緒 になって各環にそれぞれ5〜7個の原子を含む融合環構造を形成し、また場合に より1個またはそれ以上の 基R23は親水性の官能基で置換されており、そして 基R23aは同一または相異なり、それぞれR23または基OR23であって、 ここにR23は上記定義の通りであり、 Hetは芳香族の窒素、燐、または硫黄、好ましくは窒素を含む環、例え ばピリジンであることを特徴とする請求項16記載の材料。 19.W1が直鎖のアルキレン基、最も好ましくは1,2−エチレンであるこ とを特徴とする請求項18記載の材料。 20.Xが式 式中R12は同一または相異なり、それぞれ水素またはC1 〜4アルキルであ り、eは1から6、好ましくは2〜4である、 の基であることを特徴とする請求項15記載の材料。 21.請求項5〜12のいずれかで定義された重合体で被覆された基質を有す ることを特徴とする請求項14〜20のいずれかに記載の材料。 22.基質が膜の形をしていることを特徴とする請求項21記載の材料。 23.基質がポリエステル、ポリオレフィン、ポリカーボネート、ポリ塩化ビ ニル、鋼、またはセルロースもしくはシリカであることを特徴とする請求項17 または18記載の材料。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9624130.2A GB9624130D0 (en) | 1996-11-20 | 1996-11-20 | Biocompatible compositions |
GB9624130.2 | 1996-11-20 | ||
PCT/GB1997/003192 WO1998022517A1 (en) | 1996-11-20 | 1997-11-20 | Anion exchange materials and processes |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2001506915A true JP2001506915A (ja) | 2001-05-29 |
JP2001506915A5 JP2001506915A5 (ja) | 2005-05-12 |
JP4051414B2 JP4051414B2 (ja) | 2008-02-27 |
Family
ID=10803229
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52336498A Expired - Fee Related JP4051414B2 (ja) | 1996-11-20 | 1997-11-20 | 陰イオン交換材料およびその方法 |
JP52336298A Expired - Lifetime JP4295359B2 (ja) | 1996-11-20 | 1997-11-20 | 生体適合性の組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52336298A Expired - Lifetime JP4295359B2 (ja) | 1996-11-20 | 1997-11-20 | 生体適合性の組成物 |
Country Status (11)
Country | Link |
---|---|
US (2) | US6251964B1 (ja) |
EP (2) | EP0939779B1 (ja) |
JP (2) | JP4051414B2 (ja) |
AT (2) | ATE189899T1 (ja) |
AU (3) | AU5061098A (ja) |
CA (1) | CA2271132C (ja) |
DE (2) | DE69711913T2 (ja) |
ES (1) | ES2143301T3 (ja) |
GB (1) | GB9624130D0 (ja) |
WO (3) | WO1998022516A1 (ja) |
ZA (3) | ZA9710467B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003520107A (ja) * | 2000-01-24 | 2003-07-02 | バイオコンパテイブルズ・リミテツド | 被覆されたインプラント |
JP4938929B2 (ja) * | 1998-12-11 | 2012-05-23 | バイオコンパテイブルズ・ユーケイ・リミテツド | 架橋重合体、並びにそれらから形成した屈折デバイス |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743878B2 (en) | 1991-07-05 | 2004-06-01 | Biocompatibles Uk Limited | Polymeric surface coatings |
GB9522332D0 (en) | 1995-11-01 | 1996-01-03 | Biocompatibles Ltd | Braided stent |
US6258371B1 (en) * | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
DE69939469D1 (de) * | 1998-07-07 | 2008-10-16 | Nof Corp | Zusammensetzung zur wundheilung, wundverband und verfahren zur behandlung vonwunden |
AU4941100A (en) * | 1999-05-27 | 2001-02-19 | Biocompatibles Limited | Polymer solutions |
EP1180013B1 (en) | 1999-05-27 | 2006-03-08 | Biocompatibles UK Limited | Local drug delivery |
US6852816B2 (en) | 2000-10-06 | 2005-02-08 | Biocompatibles Uk Limited | Zwitterionic polymers |
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
WO2002088389A1 (fr) | 2001-04-26 | 2002-11-07 | Nof Corporation | Inhibiteurs d'hybridation non specifiques, reactifs d'examen clinique et procede d'examen clinique |
US6844028B2 (en) * | 2001-06-26 | 2005-01-18 | Accelr8 Technology Corporation | Functional surface coating |
ATE486613T1 (de) | 2002-03-07 | 2010-11-15 | Biocompatibles Uk Ltd | Mit nucleinsäure complexierte block-copolymere |
WO2005027991A1 (en) * | 2003-09-19 | 2005-03-31 | Cambridge University Technical Services Ltd | Orthopaedic devices |
US20050208093A1 (en) * | 2004-03-22 | 2005-09-22 | Thierry Glauser | Phosphoryl choline coating compositions |
US7892284B2 (en) * | 2005-02-28 | 2011-02-22 | Hoya Corporation | Intraocular lens and process for producing the same |
EP2041196B1 (en) | 2006-07-14 | 2012-11-28 | Biocompatibles UK Limited | Polymer |
JP5557373B2 (ja) | 2006-11-21 | 2014-07-23 | アボット ラボラトリーズ | 薬剤溶出性コーティングにおけるテトラフルオロエチレン、ヘキサフルオロプロピレン、及びフッ化ビニリデンのターポリマーの使用 |
US20080286332A1 (en) | 2007-05-14 | 2008-11-20 | Pacetti Stephen D | Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties |
JP5019524B2 (ja) * | 2007-06-01 | 2012-09-05 | 国立大学法人 東京大学 | 新規ポリ(メタ)アクリレート共重合体ならびに小胞体及びゴルジ体への送達方法 |
WO2010065958A1 (en) | 2008-12-05 | 2010-06-10 | Semprus Biosciences Corp. | Layered non-fouling, antimicrobial, antithrombogenic coatings |
JP6083071B2 (ja) | 2010-06-09 | 2017-02-22 | アロー インターナショナル インコーポレイテッド | 非汚染性、抗菌性、抗血栓性グラフトフロム組成物 |
WO2011156590A2 (en) | 2010-06-09 | 2011-12-15 | Semprus Biosciences Corp. | Non-fouling, anti-microbial, anti-thrombogenic graft compositions |
WO2012162789A1 (en) * | 2011-06-01 | 2012-12-06 | University Of British Columbia | Polymers for reversing heparin-based anticoagulation |
AU2012368232B2 (en) | 2011-12-14 | 2016-01-07 | Arrow International, Inc. | Imbibing process for contact lens surface modification |
JP2015507761A (ja) | 2011-12-14 | 2015-03-12 | センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. | コンタクトレンズ改質のためのレドックス法 |
CA2858730C (en) | 2011-12-14 | 2017-07-18 | Semprus Biosciences Corp. | Surface modified contact lenses |
AU2012351980B2 (en) | 2011-12-14 | 2015-09-17 | Arrow International, Inc. | Silicone hydrogel contact lens modified using Lanthanide or Transition metal oxidants |
MX2014007204A (es) | 2011-12-14 | 2015-04-14 | Semprus Biosciences Corp | Proceso de uv de multietapas para crear lentes de contacto modificadas en la superficie. |
CN103193927B (zh) * | 2013-04-27 | 2016-01-20 | 南京构友生物材料有限公司 | 可键合的血液友好聚合物及其制法与用途 |
WO2014192731A1 (ja) * | 2013-05-27 | 2014-12-04 | Jsr株式会社 | 無機材料で構成される表面用の表面処理剤、表面が改質された器具および装置、該器具および装置の製造方法 |
US10384167B2 (en) | 2013-11-21 | 2019-08-20 | Oasys Water LLC | Systems and methods for improving performance of osmotically driven membrane systems |
US10780204B2 (en) | 2014-10-02 | 2020-09-22 | Asahi Kasei Medical Co., Ltd. | Biological fluid-treating filter and filter device |
KR20180076552A (ko) * | 2016-12-28 | 2018-07-06 | 주식회사 엘지화학 | 친수성 코팅 조성물 |
CA3139542A1 (en) * | 2019-05-10 | 2020-11-19 | Trustees Of Tufts College | Zwitterionic charged copolymer membranes |
WO2022251491A1 (en) | 2021-05-27 | 2022-12-01 | Metro International Biotech, Llc | Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use |
CN113476661B (zh) * | 2021-07-05 | 2022-08-05 | 中国医学科学院生物医学工程研究所 | 一种三层结构复合型自愈合人造血管及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE306597B (ja) | 1964-12-17 | 1968-12-02 | Incentive Ab | |
US3861948A (en) * | 1972-05-22 | 1975-01-21 | Kendall & Co | Pressure sensitive adhesive tape |
US3839237A (en) * | 1972-05-31 | 1974-10-01 | Ici Australia Ltd | Ion exchange resins having both acidic and basic ion-exchange sites |
SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
SE456347B (sv) | 1982-02-09 | 1988-09-26 | Ird Biomaterial Ab | Ytmodifierat fast substrat samt forfarande for framstellning derav |
US4517241A (en) * | 1982-12-02 | 1985-05-14 | Alpert Andrew J | Chromatographic support material |
US4704324A (en) * | 1985-04-03 | 1987-11-03 | The Dow Chemical Company | Semi-permeable membranes prepared via reaction of cationic groups with nucleophilic groups |
US4865870A (en) | 1988-07-07 | 1989-09-12 | Becton, Dickinson And Company | Method for rendering a substrate surface antithrombogenic |
JP2890316B2 (ja) * | 1989-07-07 | 1999-05-10 | 科学技術振興事業団 | 生体適合性医療デバイス用材料 |
GB9023498D0 (en) | 1990-10-29 | 1990-12-12 | Biocompatibles Ltd | Soft contact lens material |
US5075399A (en) * | 1990-11-15 | 1991-12-24 | Phillips Petroleum Company | Superabsorbent crosslinked ampholytic ion pair copolymers |
CA2277953C (en) * | 1991-07-05 | 2001-01-16 | Biocompatibles Limited | Polymeric surface coatings |
AU3592693A (en) | 1992-01-21 | 1993-08-03 | University Of Utah, The | Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers |
EP0639989B1 (en) | 1992-04-24 | 2001-06-27 | Biocompatibles Limited | Method of reducing microorganism adhesion |
US5342621A (en) * | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
GB9226791D0 (en) * | 1992-12-23 | 1993-02-17 | Biocompatibles Ltd | New materials |
JPH07184989A (ja) | 1993-12-28 | 1995-07-25 | Kuraray Co Ltd | 血液適合性医療用高分子材料および医療材料 |
JPH07285831A (ja) * | 1994-04-18 | 1995-10-31 | Mitsubishi Chem Corp | 毛髪化粧料組成物 |
-
1996
- 1996-11-20 GB GBGB9624130.2A patent/GB9624130D0/en active Pending
-
1997
- 1997-11-20 US US09/117,729 patent/US6251964B1/en not_active Expired - Lifetime
- 1997-11-20 JP JP52336498A patent/JP4051414B2/ja not_active Expired - Fee Related
- 1997-11-20 JP JP52336298A patent/JP4295359B2/ja not_active Expired - Lifetime
- 1997-11-20 EP EP97913311A patent/EP0939779B1/en not_active Expired - Lifetime
- 1997-11-20 US US09/308,496 patent/US6432314B1/en not_active Expired - Lifetime
- 1997-11-20 AT AT97913308T patent/ATE189899T1/de not_active IP Right Cessation
- 1997-11-20 AT AT97913311T patent/ATE215971T1/de not_active IP Right Cessation
- 1997-11-20 AU AU50610/98A patent/AU5061098A/en not_active Abandoned
- 1997-11-20 WO PCT/GB1997/003189 patent/WO1998022516A1/en active IP Right Grant
- 1997-11-20 ZA ZA9710467A patent/ZA9710467B/xx unknown
- 1997-11-20 EP EP97913308A patent/EP0866815B1/en not_active Expired - Lifetime
- 1997-11-20 WO PCT/GB1997/003192 patent/WO1998022517A1/en active IP Right Grant
- 1997-11-20 AU AU50608/98A patent/AU728887B2/en not_active Ceased
- 1997-11-20 ZA ZA9710468A patent/ZA9710468B/xx unknown
- 1997-11-20 AU AU50611/98A patent/AU5061198A/en not_active Abandoned
- 1997-11-20 DE DE69711913T patent/DE69711913T2/de not_active Expired - Lifetime
- 1997-11-20 WO PCT/GB1997/003191 patent/WO1998022162A1/en active Application Filing
- 1997-11-20 ZA ZA9710466A patent/ZA9710466B/xx unknown
- 1997-11-20 ES ES97913308T patent/ES2143301T3/es not_active Expired - Lifetime
- 1997-11-20 DE DE69701319T patent/DE69701319T2/de not_active Expired - Lifetime
- 1997-11-20 CA CA002271132A patent/CA2271132C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4938929B2 (ja) * | 1998-12-11 | 2012-05-23 | バイオコンパテイブルズ・ユーケイ・リミテツド | 架橋重合体、並びにそれらから形成した屈折デバイス |
JP2003520107A (ja) * | 2000-01-24 | 2003-07-02 | バイオコンパテイブルズ・リミテツド | 被覆されたインプラント |
JP5000826B2 (ja) * | 2000-01-24 | 2012-08-15 | バイオコンパテイブルズ・ユーケイ・リミテツド | 被覆されたインプラント |
Also Published As
Publication number | Publication date |
---|---|
ZA9710467B (en) | 1998-11-20 |
US6432314B1 (en) | 2002-08-13 |
EP0939779B1 (en) | 2002-04-10 |
EP0866815B1 (en) | 2000-02-23 |
DE69711913D1 (de) | 2002-05-16 |
US6251964B1 (en) | 2001-06-26 |
ATE215971T1 (de) | 2002-04-15 |
DE69701319D1 (de) | 2000-03-30 |
WO1998022517A1 (en) | 1998-05-28 |
JP4051414B2 (ja) | 2008-02-27 |
EP0866815A3 (en) | 1998-10-21 |
WO1998022516A1 (en) | 1998-05-28 |
WO1998022162A1 (en) | 1998-05-28 |
EP0939779A1 (en) | 1999-09-08 |
ZA9710468B (en) | 1998-11-20 |
AU728887B2 (en) | 2001-01-18 |
ES2143301T3 (es) | 2000-05-01 |
ATE189899T1 (de) | 2000-03-15 |
JP2001504877A (ja) | 2001-04-10 |
AU5060898A (en) | 1998-06-10 |
CA2271132C (en) | 2007-04-17 |
EP0866815A2 (en) | 1998-09-30 |
GB9624130D0 (en) | 1997-01-08 |
DE69701319T2 (de) | 2000-07-13 |
ZA9710466B (en) | 1998-11-20 |
AU5061098A (en) | 1998-06-10 |
JP4295359B2 (ja) | 2009-07-15 |
AU5061198A (en) | 1998-06-10 |
DE69711913T2 (de) | 2002-10-10 |
CA2271132A1 (en) | 1998-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001506915A (ja) | 陰イオン交換材料およびその方法 | |
JP3204956B2 (ja) | ポリマーの表面コーティング | |
US6284854B1 (en) | Polymeric surface coatings | |
US6743878B2 (en) | Polymeric surface coatings | |
JP4395562B2 (ja) | 非凝血性コーティング組成物及びその使用法 | |
US6090901A (en) | Polymeric surface coatings | |
JP2890316B2 (ja) | 生体適合性医療デバイス用材料 | |
JP4195726B2 (ja) | 非凝血塊形成性ポリマーおよび抗凝血塊形成性ポリマー | |
JPH08506030A (ja) | 新規な双性イオン材料 | |
EP0714417A1 (en) | Polymer surface coatings | |
EP0753315B1 (en) | Medical material, method for production thereof, and medical apparatus | |
JP4219154B2 (ja) | 血液適合性高分子を用いた医療用器具 | |
JP4746984B2 (ja) | 生体適合性と温度応答性を併せ持つ高分子 | |
JP3480033B2 (ja) | ホスホリルコリン基又はその誘導体基含有共重合体、その製造法及び抗血栓性材料 | |
JPH10151192A (ja) | 抗血栓性組成物および医用材料 | |
US7445789B2 (en) | Biocompatible polymeric systems carrying triflusal or HTB | |
JPH10165494A (ja) | 抗血栓性組成物および医用材料 | |
MXPA00009178A (es) | Agentes compatibles con sangre reactivos latentes | |
JPH05161710A (ja) | 体液浄化用吸着材料の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040827 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040827 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20061214 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070327 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070522 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20070522 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20070522 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070821 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071009 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071026 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101214 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101214 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111214 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111214 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121214 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121214 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131214 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |